Trial Profile
An Exploratory Randomized comparative clinical trial for the preventive effect of Denosumab versus Zoledronic acid against bone loss around femoral implants after total hip arthroplasty
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 02 Jul 2019
Price :
$35
*
At a glance
- Drugs Denosumab (Primary) ; Zoledronic acid (Primary)
- Indications Osteoarthritis; Osteoporosis
- Focus Therapeutic Use
- 28 Jun 2019 Status changed from not yet recruiting to recruiting.
- 02 Jan 2018 New trial record